Does risperidone act better in schizophrenic patients who have a family or obstetric history? (Q44262084)

1 December 2017

title

Does risperidone act better in schizophrenic patients who have a family or obstetric history? (English)

1 reference

1 December 2017

0 references

1 reference

2

Janusz K Rybakowski

1 reference

1 December 2017

1

Alina Borkowska

1 reference

1 December 2017

publication date

1 December 2002

1 reference

Progress in Neuro-Psychopharmacology & Biological Psychiatry

1 December 2017

published in

1 reference

1 December 2017

volume

26

1 reference

1 December 2017

issue

7-8

1 reference

1 December 2017

page(s)

1349-1353

1 reference

Obstetric complications predict treatment response in first-episode schizophrenia

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900300-7

7 January 2021

Risperidone treatment of schizophrenia: improvement in psychopathology and neuropsychological tests

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900300-7

7 January 2021

Neuropsychological functioning in siblings discordant for schizophrenia and healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900300-7

7 January 2021

Risperidone in the treatment of negative symptoms of schizophrenia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900300-7

7 January 2021

Neuropsychological assessment of monozygotic twins discordant for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900300-7

7 January 2021

Does risperidone improve verbal working memory in treatment-resistant schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900300-7

7 January 2021

Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900300-7

7 January 2021

Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900300-7

7 January 2021

Obstetric complications and Apgar score in early-onset schizophrenic patients with prominent positive and prominent negative symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900300-7

7 January 2021

Executive-frontal lobe cognitive dysfunction in schizophrenia: a symptom subtype analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900300-7

7 January 2021

Relation of familial schizophrenia to negative symptoms but not to the deficit syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900300-7

7 January 2021

The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900300-7

7 January 2021

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900300-7

7 January 2021

Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900300-7

7 January 2021

Immediate and delayed effects of risperidone on cerebral metabolism in neuroleptic naïve schizophrenic patients: correlations with symptom change

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900300-7

7 January 2021

Response to drugs in schizophrenia: the influence of family history, obstetric complications and ventricular enlargement

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900300-7

7 January 2021

The relation of the trail making test to organic brain damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900300-7

7 January 2021

The effect of treatment with risperidone, olanzapine or phenothiazines on cognitive functions in patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900300-7

7 January 2021

Eye movement and neuropsychological studies in first-degree relatives of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900300-7

7 January 2021

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900300-7

7 January 2021

The effect of risperidone on cognition in patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900300-7

7 January 2021

Studies of interference in serial verbal reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900300-7

7 January 2021

Neurocognitive correlates of positive and negative syndromes in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900300-7

7 January 2021

Hypoxic-ischemia-related fetal/neonatal complications and risk of schizophrenia and other nonaffective psychoses: a 19-year longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900300-7

7 January 2021

10.1016/S0278-5846(02)00300-7

Identifiers

DOI

1 reference

1 December 2017

1 reference